In separate virtual addresses to the shareholders of Moderna, Pfizer, and Johnson & Johnson, Oxfam America will call on the pharmaceutical corporations to improve vaccine equity and access so that everyone, everywhere has access to these life-saving shots. Oxfam’s resolutions to Moderna and Pfizer seek support from shareholders to encourage the companies to study the feasibility of transferring vaccine technology and know-how to urgently ramp up production around the world. In a separate resolution before Johnson & Johnson shareholders, Oxfam seeks transparency on how the company determines pricing for its COVID vaccines in light of the billions of public funding from US taxpayers the company received.
Dr. Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization, presenting the Oxfam resolution to Moderna shareholders.
Ady Barkan, Founder and Co-Executive Director of Be A Hero, presenting the Oxfam resolution to Pfizer shareholders.
Maaza Seyoum, Global South Convener, People’s Vaccine Alliance, presenting the Oxfam resolution to Johnson & Johnson shareholders.
WHEN: April 28, 2022
WHERE: Moderna, Pfizer, and Johnson & Johnson Annual General Meetings
To receive further updates and see the video addresses, please contact [email protected].
More than two years into the COVID-19 pandemic and a year after the introduction of highly effective life-saving vaccines, 74 percent of people in high-income countries are fully vaccinated, while just 12 percent of people in low-income countries are. Moderna, Pfizer, and Johnson & Johnson have continued to prioritize short-term profit-making over long-term sustainability and reputational risks, as well as public health needs. Continued vaccine inequity will not only cause more deaths and suffering around the world, it also threatens to further devastate the global economy.